SCHEMBL1372818

SCHEMBL1372818

CCOC(=O)c1cc2cccnc2n(C)c1=O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AHR P35869 1/20 0.55
ELANE P08246 3/20 0.49
CNR2 P34972 3/20 0.48
KDM4E B2RXH2 4/20 0.46
ALDH1A1 P00352 3/20 0.46
GAA P10253 3/20 0.46
HPGD P15428 3/20 0.46
HSD17B10 Q99714 1/20 0.46
GLA P06280 2/20 0.46
POLB P06746 1/20 0.46
STAT6 P42226 1/20 0.46
KMT2A Q03164 1/20 0.46
HIF1A Q16665 1/20 0.46
LMNA P02545 1/20 0.46
HTT P42858 1/20 0.45
MAOA P21397 1/20 0.44
MAOB P27338 1/20 0.44
ADORA3 P0DMS8 1/20 0.44
BRD4 O60885 1/20 0.43
CNR1 P21554 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3517555 0.87 ELANE (0.49) ELANECNR2KDM4EALDH1A1GAA
SCHEMBL1375898 0.85 AHR (0.61) AHRCNR2KDM4EALDH1A1GAA
SCHEMBL1375494 0.84 MET (0.52) ELANEKDM4EALDH1A1GAAHPGD
SCHEMBL15334959 0.83 CNR2 (0.49) ELANECNR2KDM4EALDH1A1GAA
SCHEMBL1423321 0.83 LMNA (0.48) ELANEKDM4EALDH1A1HPGDHSD17B10
SCHEMBL1374001 0.81 CNR1 (0.59) CNR2KDM4EALDH1A1GAAHPGD
SCHEMBL1372639 0.81 AHR (0.62) AHRCNR2KDM4EALDH1A1CNR1
SCHEMBL17619480 0.80 ELANE (0.43) ELANECNR2KDM4EALDH1A1GAA
Hydrochloric Acid SCHEMBL1373594 0.80 AHR (0.60) AHRCNR2KDM4EALDH1A1CNR1
SCHEMBL1373592 0.80 AHR (0.60) AHRCNR2CNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12479822-B2 AHR agonists ELI LILLY AND COMPANY (US) 2025-11-25 US disclosed
EP-4402128-A1 AHR AGONISTS Eli Lilly and Company (US) 2024-07-24 EP disclosed
CN-118215655-A AHR agonists 伊莱利利公司 2024-06-18 CN disclosed
US-20230159493-A1 AHR AGONISTS ELI LILLY AND COMPANY 2023-05-25 US disclosed
WO-2023039275-A1 AHR AGONISTS ELI LILLY AND COMPANY (US) 2023-03-16 WO disclosed
EP-2394995-B1 RING-FUSED 2-PYRIDONE DERIVATIVES AND HERBICIDES KUMIAI CHEMICAL INDUSTRY CO (JP) 2014-01-15 EP disclosed
US-8334236-B2 Ring-fused 2-pyridone derivatives and herbicides KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) 2012-12-18 US disclosed
EP-2394995-A1 RING-FUSED 2-PYRIDONE DERIVATIVES AND HERBICIDES Kumiai Chemical Industry CO., LTD. (JP) 2011-12-14 EP disclosed
US-20110287937-A1 RING-FUSED 2-PYRIDONE DERIVATIVES AND HERBICIDES IHARA CHEMICAL INDUSTRY CO., LTD. (JP) 2011-11-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230159493-A1 AHR AGONISTS AHR, ARNT, RORC AHR 1/4885ELANE 1418/4885CNR2 80/4885
US-20110287937-A1 RING-FUSED 2-PYRIDONE DERIVATIVES AND HERBICIDES CBR3, CBR1, CHRM1 AHR 376/4885ELANE 4755/4885CNR2 516/4885
US-12479822-B2 AHR agonists AHR, ARNT, RORC AHR 1/4885ELANE 1418/4885CNR2 80/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.